Method For Activating Efferent Sympathetic Nerves Innervating Adipose Tissues To Improve Obesity And Symptoms Associated Therewith
First Claim
Patent Images
1. A method for activating an efferent sympathetic nerve innervating an adipose tissue, comprising stimulating an afferent vagal nerve from the liver without directly enhancing peroxisome proliferator-activated receptor (PPAR)-γ
- 2 function in the liver.
1 Assignment
0 Petitions
Accused Products
Abstract
A method for activating an efferent sympathetic nerve innervating an adipose tissue and improving obesity-associated symptoms is provided, comprising stimulating an afferent vagal nerve from the liver without directly enhancing peroxisome proliferator-activated receptor (PPAR)-γ2 function in the liver.
-
Citations
12 Claims
-
1. A method for activating an efferent sympathetic nerve innervating an adipose tissue, comprising stimulating an afferent vagal nerve from the liver without directly enhancing peroxisome proliferator-activated receptor (PPAR)-γ
- 2 function in the liver.
-
2. A method for diminishing an adipose tissue, comprising stimulating an afferent vagal nerve from the liver without directly enhancing PPARγ
- 2 function in the liver.
- View Dependent Claims (3)
-
4. A method for increasing systemic energy expenditure, comprising stimulating an afferent vagal nerve from the liver without directly enhancing PPARγ
- 2 function in the liver.
-
5. A method for suppressing weight gain or obesity, comprising stimulating an afferent vagal nerve from the liver without directly enhancing PPARγ
- 2 function in the liver.
-
6. A method for improving an obesity-associated symptom, comprising stimulating an afferent vagal nerve from the liver without directly enhancing PPARγ
- 2 function in the liver.
- View Dependent Claims (7)
- 8. A method for screening for a substance for weight reduction, comprising screening for a substance that excites an afferent vagal nerve from the liver.
- 10. A method for screening for a substance for improving an obesity-associated symptom, comprising screening for a substance that excites an afferent vagal nerve from the liver.
Specification